RADIOIMMUNOASSAYS FOR GLUCAGONLIKE PEPTIDE-1 AND PEPTIDE-2 (GLP-1 AND GLP-2)

被引:0
|
作者
ORSKOV, C [1 ]
HOLST, JJ [1 ]
机构
[1] UNIV COPENHAGEN,PANUM INST,INST MED PHYSIOL C,BLEGDAMSVEJ 3,DK-2200 COPENHAGEN N,DENMARK
关键词
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
引用
收藏
页码:165 / 174
页数:10
相关论文
共 50 条
  • [41] Glucagon-like peptide-2 (GLP-2) increases mesenteric blood flow in humans
    Bremholm, Lasse
    Hornum, Mads
    Henriksen, Birthe
    Larsen, Steen
    Holst, Jens J.
    GASTROENTEROLOGY, 2007, 132 (04) : A241 - A241
  • [42] Physiology and pathophysiology of glucagon-like peptide-1 (GLP-1): The role of GLP-1 in the pathogenesis of diabetes mellitus, obesity, and stress
    Bojanowska, E
    MEDICAL SCIENCE MONITOR, 2005, 11 (08): : RA271 - RA278
  • [43] Identification of glucagon-like peptide-2 (GLP-2)-activated signaling pathways in baby hamster kidney fibroblasts expressing the rat GLP-2 receptor
    Yusta, B
    Somwar, R
    Wang, F
    Munroe, D
    Grinstein, S
    Klip, A
    Drucker, DJ
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (43) : 30459 - 30467
  • [44] New developments in the biology of the glucagon-like peptides GLP-1 and GLP-2
    Drucker, DJ
    Lovshin, J
    Baggio, L
    Nian, M
    Adatia, F
    Boushey, RP
    Liu, YF
    Saleh, J
    Yusta, B
    Scrocchi, L
    VIP, PACAP, GLUCAGON, AND RELATED PEPTIDES, 2000, 921 : 226 - 232
  • [45] GLUCAGONLIKE PEPTIDES GLP-1 AND GLP-2, PREDICTED PRODUCTS OF THE GLUCAGON GENE, ARE SECRETED SEPARATELY FROM PIG SMALL-INTESTINE BUT NOT PANCREAS
    ORSKOV, C
    HOLST, JJ
    KHUHTSEN, S
    BALDISSERA, FGA
    POULSEN, SS
    NIELSEN, OV
    ENDOCRINOLOGY, 1986, 119 (04) : 1467 - 1475
  • [46] Minor Contribution of Endogenous GLP-1 and GLP-2 to Postprandial Lipemia in Obese Men
    Matikainen, Niina
    Bjornson, Elias
    Soderlund, Sanni
    Boren, Christofer
    Eliasson, Bjorn
    Pietillaien, Kirsi H.
    Bogl, Leonie H.
    Hakkarainen, Antti
    Lundbom, Nina
    Rivellese, Angela
    Riccardi, Gabriele
    Despres, Jean-Pierre
    Almeras, Natalie
    Holst, Jens Juul
    Deacon, Carolyn F.
    Boren, Jan
    Taskinen, Marja-Riitta
    PLOS ONE, 2016, 11 (01):
  • [47] Pharmacological Characterization of FE 203799, a Novel Long Acting Peptide Analog of Glucagon-Like Peptide-2 (GLP-2)
    Hargrove, Diane M.
    Alagarsamy, Sudar
    Qi, Steve
    Srinivasan, Karthik
    Croston, Glenn
    Laporte, Regent
    Sueiras-Diaz, Javier
    Wisniewski, Kazimierz
    Hartwig, Jennifer
    Wisniewska, Halina T.
    Lu, Mark
    Posch, Alexander P.
    Schteingart, Claudio P.
    Riviere, Pierre J.
    GASTROENTEROLOGY, 2011, 140 (05) : S293 - S293
  • [48] Serum levels of glucagon-like peptide (GLP)-1 and GLP-2 in patients with Hashimoto's thyroiditis
    Jin, Yue
    Liu, Hong
    Ma, Shao-Gang
    Cheng, Jian-Ping
    Zhang, Kai
    JOURNAL OF RESEARCH IN MEDICAL SCIENCES, 2015, 20 (02): : 174 - 177
  • [49] Insulin as a feedback regulator of glucagon-like peptide-1 (GLP-1) release?
    Brunn, C
    Schloos, J
    Lemansky, P
    Sewing, S
    Mest, HJ
    BRITISH JOURNAL OF PHARMACOLOGY, 1999, 128 : U59 - U59
  • [50] The glucagon-like peptide-1 (GLP-1) drugs poised to conquer obesity
    Yin, Jun
    Liu, Yuexing
    Jia, Weiping
    Chinese Science Bulletin, 2024, 69 (35) : 5094 - 5099